Publications by authors named "Astrid Kramer"

Claim this Profile
C
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness.
Haoyue Wang, Astrid Kramer, Marjolein J E Greuter, Carmen Rubio-Alarcón, Birgit Lissenberg-Witte

Ther Adv Med Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology.
Astrid Kramer, Lucas F van Schaik, Daan van den Broek, Gerrit A Meijer, Iñaki Gutierrez Ibarluzea

Pharmacoeconomics· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.
Astrid Kramer, Carmen Rubio-Alarcón, Daan van den Broek, Daan C L Vessies, Iris Van't Erve

Mol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer.
Astrid Kramer, Marjolein J E Greuter, Suzanna J Schraa, Geraldine R Vink, Jillian Phallen

Ther Adv Med Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.
Astrid Kramer, Ed Schuuring, Daan C L Vessies, Paul van der Leest, Maartje J Geerlings

J Mol Diagn· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.
Melanie Lindenberg, Astrid Kramer, Esther Kok, Valesca Retèl, Geerard Beets

BMC Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.
Simone N Koole, Daan C L Vessies, Milou M F Schuurbiers, Astrid Kramer, Robert D Schouten

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognizing and defining true Ras binding domains I: biochemical analysis.
Sabine Wohlgemuth, Christina Kiel, Astrid Krämer, Luis Serrano, Fred Wittinghofer

J Mol Biol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis